ChhabraSTKaurTMassonS, et al.Early onset ACS: an age based clinico-epidemiologic and angiographic comparison. Atherosclerosis. 2018;279:45–51.
2.
EstebanMRMonteroSMSanchezJJ, et al.Acute coronary syndrome in the young: clinical characteristics, risk factors and prognosis. Open Cardiovasc Med J.2014;8:61–7.
3.
DoughtyMMehtaRBruckmanD, et al.Acute myocardial infarction in the young–The University of Michigan Experience. Am Heart J. 2002;143:56–62.
4.
AvezumAMakdisseMSpencerF, et al.Impact of age on management and outcome of acute coronary syndrome: observations from the global registry of acute coronary events (GRACE). Am Heart J. 2005;149:67–73.
5.
YunyunWTongLYingwuL, et al.Analysis of risk factors of ST-segment elevation myocardial infarction in young patients. BMC Cardiovasc Disord. 2014;14:179–83.
6.
ChenYLBhasinAYoussefAA, et al.Prognostic factors and outcomes in young Chinese patients with acute myocardial infarction undergoing primary coronary angioplasty. Int Heart J. 2009;50:1–11.
7.
MorillasPBertomeuVPabonP, et al.Characteristics and outcome of acute myocardial infarction in young patients. The PRIAMHO II study. Cardiology. 2007;107:217–25.
8.
TsaiWCWuKYLinGM, et al.Clinical characteristics of patients less than forty years old with coronary artery disease in Taiwan: a cross-sectional study. Acta Cardiol Sin. 2017;33:233–40.
9.
RathodKSJonesDAGallagherS, et al.Atypical risk factor profile and excellent long-term outcomes of young patients treated with primary percutaneous coronary intervention for ST-elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2016;5:23–32.
10.
TungsubutraWTresukosolDBuddhariWWatanaBSoponSBoonchuS, Thai ACS Registry. Acute coronary syndrome in young adults: the Thai ACS registry. J Med Assoc Thai. 2007;90:81–90.
11.
ChanMYSunJLNewbyLK, et al.Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction. Circulation. 2009;119:3110–7.
12.
RoeMTParsonsLSPollackCVJr, et al.Quality of care by classification of myocardial infarction: treatment patterns for ST-segment elevation vs non-ST-segment elevation myocardial infarction. Arch Intern Med.2005;165:1630–6.
13.
MingGWaiouZZhiguoZ, et al.Clinical characteristics and outcomes in young patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention. Am J Med Sci. 2018;355:544–52.
14.
CutlipDEWindeckerSMehranR, et al.Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344–51.
15.
JamilGJamilMAlkhazrajiH, et al.Risk factor assessment of young patients with ST-segment elevation myocardial infarction. Am J Cardiovasc Dis. 2013;3:170–4.
16.
YangWXYangZWuYJShu-binQYue JinYJi LinC. Factors associated with coronary artery disease in young population (age 40): analysis with 217 cases. Chin Med Sci J. 2014;29:38–42.
17.
BhardwajRKandoriaASharmaR. Myocardial infarction in young adults—risk factors and pattern of coronary artery involvement. Niger Med J. 2014;55:44–7.
18.
TwigGYanivGLevineH, et al.Body-mass index in 2.3 million adolescents and cardiovascular death in adulthood. N Engl J Med. 2016;374:2430–40.
19.
SukhijaRAronowWSNayakDAhnCWeissMB. Increased fasting plasma insulin concentrations are associated with the severity of angiographic coronary artery disease. Angiology. 2005;56:249–51.
20.
AlexandreDMSFelipeLFMaria CarolinaFASSerranoCVJrDe OliveiraMTJr. Clinical characteristics and long-term progression of young patients with acute coronary syndrome in Brazil. Einstein. 2015;13:370–5.
21.
KumarNSharmaSMohanB, et al.Clinical and angiographic profile of patients presenting with first acute myocardial infarction in a tertiary care center in Northern India. Indian Heart J. 2008;60:210–14.
22.
LeeJHParkHSChaeSC, et al.Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction. Am J Cardiol. 2009;104:182–9.
23.
LekstonATajstraMGasiorM, et al.Impact of multivessel coronary disease on one-year clinical outcomes and five-year mortality in patients with ST elevation myocardial infarction undergoing percutaneous coronary intervention. Kardiol Pol. 2011;69:336–43.
24.
JamesSKArmstrongPBarnathanE, et al.Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a Gusto-IV Substudy. J Am Coll Cardiol. 2003;41:916–24.
25.
VeldersMAWallentinLBeckerRC, et al.Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the platelet inhibition and patient outcomes trial. Am Heart J. 2015;169:879–89.
26.
Wen XiaFTie NanZXiao ZengWLeiZQuan MinJYa LingH. Sex-related differences in short- and long-term outcome among young and middle-aged. Patients for ST-segment elevation myocardial infarction underwent percutaneous coronary intervention. Chin Med J. 2018;131:121420.
27.
KangSHSuhJWYoonCH, et al.Sex differences in management and mortality of patients with ST-elevation myocardial infarction (from the Korean acute myocardial infarction national registry). Am J Cardiol. 2012;109:787-93.
28.
ZhangZFangJGillespieC, et al.Age-specific gender differences in in-hospital mortality by type of acute myocardial infarction. Am J Cardiol. 2012;109:1097-103.
29.
McCulloughPA. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008;51:1419–28.
30.
MarenziGLauriEAssanelliS, et al.Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004;44:1780–5.
31.
NarulaAMehranRWeiszG, et al.Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy. Eur Heart J. 2014;35:1533–40.
32.
NakahashiHKosugeMSakamakiK, et al.Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention. Heart Vessels. 2017;32:22–9.
33.
YangYGeorgeKCLuoR, et al.Contrast-induced acute kidney injury and adverse clinical outcomes risk in acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis. BMC Nephrol. 2018;19:374.
34.
AkoJMorinoYOkuizumiKUsamiMNakamuraM. Japanese postmarketing surveillance of clopidogrel in patients with non-ST-segment elevation acute coronary syndrome, stable angina, old myocardial infarction, and ST-segment elevation myocardial infarction after percutaneous coronary intervention in a real-life setting: the final report (J-PLACE Final). Cardiovasc Interv Ther. 2016;31:101–13.
